Can psychedelics really treat the wide range of conditions being considered? The post Is the Psychedelics Industry Running Too Fast and Too Furious? appeared...
Can psychedelics really treat the wide range of conditions being considered? The post Is the Psychedelics Industry Too Fast and Too Furious? appeared...
The article Apex Labs Granted Approval for At-Home Phase 2b Psilocybin Trial was originally published on Microdose. Under-the-radar psychedelic firm Apex...
The Biden administration recently announced its plans to end the COVID Public Health Emergency (“PHE”) on May 11, 2023. This announcement has left...
The company has raised $39 million to optimize existing substances, which they say will make them safer and more effective. The post Gilgamesh Tweaks Known...
The article News You Might Have Missed: Jan 30th, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
Source: Streetwise Reports 01/25/2023 Streetwise Reports sat down with Øyvind Schanke, the chief investment officer of TD Veen and the former...
Traditional tactics aren't always the most effective ways to raise capital. The post Psychedelics Industry Goal: Find Capital ASAP appeared first on Green...
The article Small Pharma DMT Depression Trial: 57% of Patients Enter Remission was originally published on Microdose. Today, psychedelic medicine company...
The article Small Pharma Reports Positive Results from Phase IIa DMT Trial was originally published on Microdose. Big news as Small Pharma has announced...